Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bavencio
Pharma
ASCO: Merck KGaA's Bavencio combo misses survival mark in RCC
Although the overall survival miss won't cost Bavencio its FDA approval, it puts the drug further behind rival PD-1 combos from Merck & Co. and BMS.
Angus Liu
May 23, 2024 5:00pm
Pfizer says $43B buyout of Seagen will be complete this week
Dec 12, 2023 10:56am
ESMO: BMS' Opdivo bladder cancer win overshadowed
Oct 22, 2023 10:30am
Merck KGaA, Pfizer part ways on cancer drug Bavencio
Mar 28, 2023 10:15am
ESMO: Seagen's Padcev with Keytruda make case for bladder nod
Sep 7, 2022 6:05pm
Pfizer and Merck KGaA win over NICE in Bavencio reversal
Apr 7, 2022 11:42am
